… pneumonitis do not clinically improve with corticosteroids alone and require further
immunosuppression. This phenomenon, termed steroid-refractory ICI-pneumonitis… for COVID-19 …

… To identify whether corticosteroids were beneficial to COVID-19 patients. … A total of 1514
severe and 249 critical hospitalized COVID-19 patients from 2 medical centers in Wuhan, China. …

… that low-dose dexamethasone (6 mg) is sufficient [15]. In our case, dexamethasone 10 mg
was … In our case, CMV pneumonitis occurred 1 week after dexamethasone course and after …

… Although routine corticosteroids should be avoided due to … COVID-19 infection or compromise
immunotherapy efficacy. Conversely, symptoms may rapidly improve if the pneumonitis is …

… The cornerstone of drug-induced pneumonitis treatment are corticosteroids, since the
underlying mechanism of lung damage is the inflammatory and/or the immunological process. In …

… The goal of this review is to illuminate dexamethasone and methylprednisolone, ie, in terms
… in COVID-19 patients suffering from pneumonia, the proposed mode of action in COVID-19, …

… SARS-CoV-2 pneumonitis in our hospital, following … corticosteroids in the ICU at our site
during the first wave in the UK. However, given the now-established benefit of dexamethasone …

… raised the question: “Although RECOVERY along with other cohort studies report positive
effects with corticosteroids on morbidity and mortality of COVID-19, treatment approaches …

… that combining dexamethasone with fast long-… dexamethasone’s anti-inflammatory and
immunosuppressant effects kick in. Our studies demonstrated that LABAs and dexamethasone (…

… the clinical evolution of COVID-19 pneumonia and may help … in the pathogenesis of COVID-19
pneumonia, a therapeutic … , the use of systemic corticosteroids (CS) in COVID-19, highly …